MTD:NYE-Mettler-Toledo International Inc (USD)

COMMON STOCK | Diagnostics & Research |

Last Closing

USD 1443.03

Change

+40.34 (+2.88)%

Market Cap

N/A

Volume

0.07M

Analyst Target

USD 865.00
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-19 )

Largest Industry Peers for Diagnostics & Research

Symbol Name Price(Change) Market Cap
DHR Danaher Corporation

+4.53 (+1.67%)

USD 199.35B
IQV IQVIA Holdings Inc

+1.95 (+0.80%)

USD 43.52B
A Agilent Technologies Inc

+2.94 (+2.11%)

USD 40.79B
LH Laboratory Corporation of Amer..

-2.63 (-1.16%)

USD 18.96B
DGX Quest Diagnostics Incorporated

-0.36 (-0.23%)

USD 17.18B
CRL Charles River Laboratories

+3.52 (+1.71%)

USD 10.65B
QGEN Qiagen NV

-0.09 (-0.20%)

USD 10.30B
VNRX Volitionrx Ltd

+0.03 (+4.92%)

USD 0.06B
ENZ Enzo Biochem Inc

+0.03 (+2.70%)

USD 0.06B
TMO Thermo Fisher Scientific Inc

+10.13 (+1.66%)

N/A

ETFs Containing MTD

MCSE Martin Currie Sustainable.. 5.12 % 0.00 %

+0.49 (+0.28%)

N/A
EPRE 4.58 % 0.00 %

N/A

N/A
ASRP:XETRA BNP Paribas Easy ECPI Glo.. 2.39 % 0.00 %

+0.06 (+0.28%)

N/A
XMLC:F L&G Clean Water UCITS ETF 2.27 % 0.00 %

+0.07 (+0.28%)

N/A
MEDTE:PA BNP Paribas Easy ECPI Glo.. 2.19 % 0.00 %

+0.06 (+0.28%)

N/A
MTUSD:PA BNP Paribas Easy ECPI Glo.. 2.19 % 0.00 %

+0.03 (+0.28%)

N/A
XLVE:CA Mulvihill U.S. Health Car.. 1.82 % 0.00 %

-0.03 (0.28%)

N/A
ZUH:CA BMO Equal Weight US Healt.. 1.69 % 0.39 %

+0.45 (+0.28%)

CAD 0.27B
HECO 0.00 % 0.95 %

N/A

N/A
IBB iShares Biotechnology ETF 0.00 % 0.47 %

+1.95 (+0.28%)

USD 7.64B
QRI:CA 0.00 % 1.06 %

N/A

N/A
ZHU:CA BMO Equal Weight US Healt.. 0.00 % 0.00 %

+0.28 (+0.28%)

CAD 0.01B
YXM.B:CA 0.00 % 0.69 %

N/A

N/A
MJJ 0.00 % 0.00 %

N/A

N/A
MJO 0.00 % 0.00 %

N/A

N/A
BMED BlackRock Future Health E.. 0.00 % 0.00 %

+0.29 (+0.28%)

USD 4.21M
DWEQ 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Diagnostics & Research) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 18.97% 92% A 79% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 18.97% 92% A 75% C
Trailing 12 Months  
Capital Gain 31.90% 100% F 80% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 31.90% 100% F 77% C+
Trailing 5 Years  
Capital Gain 103.48% 92% A 87% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 103.48% 92% A 85% B
Average Annual (5 Year Horizon)  
Capital Gain 16.79% 92% A 80% B-
Dividend Return 16.79% 92% A 78% C+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 30.88% 38% F 33% F
Risk Adjusted Return 54.37% 85% B 72% C
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.